Skip to content
About
Our Science
Leadership
Corporate Team
R&D Team
Scientific Advisory Board
News Room
News Releases
Investors
About
Our Science
Leadership
Corporate Team
R&D Team
Scientific Advisory Board
News Room
News Releases
Investors
About
Our Science
Leadership
Corporate Team
R&D Team
Scientific Advisory Board
News Room
News Releases
Investors
About
Our Science
Leadership
Corporate Team
R&D Team
Scientific Advisory Board
News Room
News Releases
Investors
INVEST
Investors
Play Video
“Modest valuation, upcoming re-rating catalysts, and large untapped opportunity makes Shackelford a key name to monitor.”
- Intro-Act Inc. Vol 177 January 18, 2023.
To contact investor relations, please email us at
investors@shackelfordpharma.com
Invest in Shackelford
Shackelford Pharma’s Regulation A Financing is now open. Investors are required to fill out the form below to begin the investment process.
Please check your JUNK/SPAM email folder if your invitation email from Dealmaker/Shackelford does not arrive in your inbox.
Invest Shackelford
FIRST NAME
*
First
LAST NAME
Last
PHONE NUMBER
*
EMAIL
*